Search Results - JOSEPH, MAGDALENE
- Showing 1 - 10 results of 10
-
1
-
2
Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell Cancers by SHARMA, ANAND, BABRA, DESHVEER S., JOSHI, PRIYA V., HALL, MARCIA, GOGBASHIAN, ANDREW, VASDEV, NIKHIL, JOSEPH, MAGDALENE, YAZDAN, AMIR, KANFER, EDWARD
Published 2020Text -
3
Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review by Chen, Miaoqi, Rai, Ridesh, Fox, Louis, Moss, Charlotte Louise, George, Gincy, Karagiannis, Sophia N, Enting, Deborah, Joseph, Magdalene, Peat, Nicola, Russell, Beth, Van Hemelrijck, Mieke
Published 2021Text -
4
Cohort profile: King’s Health Partners bladder cancer biobank by Kotecha, Pinky, Moss, Charlotte L., Enting, Deborah, Gillett, Cheryl, Joseph, Magdalene, Josephs, Debra, Rudman, Sarah, Hughes, Simon, Cahill, Fidelma, Wylie, Harriet, Haire, Anna, Rosekilly, James, Khan, Muhammad Shamin, Nair, Rajesh, Thurairaja, Ramesh, Malde, Sachin, Van Hemelrijck, Mieke
Published 2020Text -
5
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer by Wu, Yin, Biswas, Dhruva, Usaite, Ieva, Angelova, Mihaela, Boeing, Stefan, Karasaki, Takahiro, Veeriah, Selvaraju, Czyzewska-Khan, Justyna, Morton, Cienne, Joseph, Magdalene, Hessey, Sonya, Reading, James, Georgiou, Andrew, Al-Bakir, Maise, McGranahan, Nicholas, Jamal-Hanjani, Mariam, Hackshaw, Allan, Quezada, Sergio A., Hayday, Adrian C., Swanton, Charles
Published 2022Text -
6
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike by Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Lista, Maria Jose, Jimenez-Guardeno, Jose M, Laing, Adam G., Wu, Yin, Joseph, Magdalene, Muir, Luke, Ng, Weng M., Duyvesteyn, Helen M. E., Zhao, Yuguang, Bowden, Thomas A., Shankar-Hari, Manu, Rosa, Annachiara, Cherepanov, Peter, McCoy, Laura E., Hayday, Adrian C., Neil, Stuart J.D., Malim, Michael H., Doores, Katie J.
Published 2021Text -
7
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant by Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Dupont, Liane, Lista, Maria Jose, Jimenez-Guardeño, Jose M., Laing, Adam G., Wu, Yin, Joseph, Magdalene, Muir, Luke, van Gils, Marit J., Ng, Weng M., Duyvesteyn, Helen M.E., Zhao, Yuguang, Bowden, Thomas A., Shankar-Hari, Manu, Rosa, Annachiara, Cherepanov, Peter, McCoy, Laura E., Hayday, Adrian C., Neil, Stuart J.D., Malim, Michael H., Doores, Katie J.
Published 2021Text -
8
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study by Monin, Leticia, Laing, Adam G, Muñoz-Ruiz, Miguel, McKenzie, Duncan R, del Molino del Barrio, Irene, Alaguthurai, Thanussuyah, Domingo-Vila, Clara, Hayday, Thomas S, Graham, Carl, Seow, Jeffrey, Abdul-Jawad, Sultan, Kamdar, Shraddha, Harvey-Jones, Elizabeth, Graham, Rosalind, Cooper, Jack, Khan, Muhammad, Vidler, Jennifer, Kakkassery, Helen, Sinha, Shubhankar, Davis, Richard, Dupont, Liane, Francos Quijorna, Isaac, O'Brien-Gore, Charlotte, Lee, Puay Ling, Eum, Josephine, Conde Poole, Maria, Joseph, Magdalene, Davies, Daniel, Wu, Yin, Swampillai, Angela, North, Bernard V, Montes, Ana, Harries, Mark, Rigg, Anne, Spicer, James, Malim, Michael H, Fields, Paul, Patten, Piers, Di Rosa, Francesca, Papa, Sophie, Tree, Timothy, Doores, Katie J, Hayday, Adrian C, Irshad, Sheeba
Published 2021Text -
9
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis by Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R., Hayday, Thomas S., Francos-Quijorna, Isaac, Kamdar, Shraddha, Joseph, Magdalene, Davies, Daniel, Davis, Richard, Jennings, Aislinn, Zlatareva, Iva, Vantourout, Pierre, Wu, Yin, Sofra, Vasiliki, Cano, Florencia, Greco, Maria, Theodoridis, Efstathios, Freedman, Joshua, Gee, Sarah, Chan, Julie Nuo En, Ryan, Sarah, Bugallo-Blanco, Eva, Peterson, Pärt, Kisand, Kai, Haljasmägi, Liis, Chadli, Loubna, Moingeon, Philippe, Martinez, Lauren, Merrick, Blair, Bisnauthsing, Karen, Brooks, Kate, Ibrahim, Mohammad A. A., Mason, Jeremy, Lopez Gomez, Federico, Babalola, Kola, Abdul-Jawad, Sultan, Cason, John, Mant, Christine, Seow, Jeffrey, Graham, Carl, Doores, Katie J., Di Rosa, Francesca, Edgeworth, Jonathan, Shankar-Hari, Manu, Hayday, Adrian C.
Published 2020Text -
10
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis by Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R., Hayday, Thomas S., Francos-Quijorna, Isaac, Kamdar, Shraddha, Joseph, Magdalene, Davies, Daniel, Davis, Richard, Jennings, Aislinn, Zlatareva, Iva, Vantourout, Pierre, Wu, Yin, Sofra, Vasiliki, Cano, Florencia, Greco, Maria, Theodoridis, Efstathios, Freedman, Joshua D., Gee, Sarah, Chan, Julie Nuo En, Ryan, Sarah, Bugallo-Blanco, Eva, Peterson, Pärt, Kisand, Kai, Haljasmägi, Liis, Chadli, Loubna, Moingeon, Philippe, Martinez, Lauren, Merrick, Blair, Bisnauthsing, Karen, Brooks, Kate, Ibrahim, Mohammad A. A., Mason, Jeremy, Lopez Gomez, Federico, Babalola, Kola, Abdul-Jawad, Sultan, Cason, John, Mant, Christine, Seow, Jeffrey, Graham, Carl, Doores, Katie J., Di Rosa, Francesca, Edgeworth, Jonathan, Shankar-Hari, Manu, Hayday, Adrian C.
Published 2020Text